Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
Scope of the Report:
Based on device type the market is segmented into control - to - range (CTR) system, threshold suspended device system and control - to - target (CTT) system.
The worldwide market for Artificial Pancreas Device System is expected to grow at a CAGR of roughly 19.1% over the next five years, will reach 310 million US$ in 2023, from 110 million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Artificial Pancreas Device System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Medtronic
Johnson & Johnson
TypeZero Technologies, LLC
Tandem Diabetes
Pancreum
Insulet
Beta Bionics
Animas Corporation
LLC
Bigfoot Biomedical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Control-to-Range (CTR) System
Threshold Suspended Device System
Control - to - Target (CTT) System
Market Segment by Applications, can be divided into
Hospital
Clinic
Others
There are 15 Chapters to deeply display the global Artificial Pancreas Device System market.
Chapter 1, to describe Artificial Pancreas Device System Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Artificial Pancreas Device System, with sales, revenue, and price of Artificial Pancreas Device System, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Artificial Pancreas Device System, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Artificial Pancreas Device System market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Artificial Pancreas Device System sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Artificial Pancreas Device System Introduction
1.2 Market Analysis by Type
1.2.1 Control-to-Range (CTR) System
1.2.2 Threshold Suspended Device System
1.2.3 Control - to - Target (CTT) System
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.2 Artificial Pancreas Device System Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Artificial Pancreas Device System Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 TypeZero Technologies, LLC
2.3.1 Business Overview
2.3.2 Artificial Pancreas Device System Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 TypeZero Technologies, LLC Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Tandem Diabetes
2.4.1 Business Overview
2.4.2 Artificial Pancreas Device System Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Tandem Diabetes Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pancreum
2.5.1 Business Overview
2.5.2 Artificial Pancreas Device System Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pancreum Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Insulet
2.6.1 Business Overview
2.6.2 Artificial Pancreas Device System Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Insulet Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Beta Bionics
2.7.1 Business Overview
2.7.2 Artificial Pancreas Device System Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Beta Bionics Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Animas Corporation
2.8.1 Business Overview
2.8.2 Artificial Pancreas Device System Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Animas Corporation Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 LLC
2.9.1 Business Overview
2.9.2 Artificial Pancreas Device System Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 LLC Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bigfoot Biomedical
2.10.1 Business Overview
2.10.2 Artificial Pancreas Device System Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bigfoot Biomedical Artificial Pancreas Device System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Artificial Pancreas Device System Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Artificial Pancreas Device System Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Artificial Pancreas Device System Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Artificial Pancreas Device System Manufacturer Market Share in 2017
3.3.2 Top 6 Artificial Pancreas Device System Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Artificial Pancreas Device System Market Analysis by Regions
4.1 Global Artificial Pancreas Device System Sales, Revenue and Market Share by Regions
4.1.1 Global Artificial Pancreas Device System Sales and Market Share by Regions (2013-2018)
4.1.2 Global Artificial Pancreas Device System Revenue and Market Share by Regions (2013-2018)
4.2 North America Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
4.3 Europe Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
4.5 South America Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
5 North America Artificial Pancreas Device System by Countries
5.1 North America Artificial Pancreas Device System Sales, Revenue and Market Share by Countries
5.1.1 North America Artificial Pancreas Device System Sales and Market Share by Countries (2013-2018)
5.1.2 North America Artificial Pancreas Device System Revenue and Market Share by Countries (2013-2018)
5.2 United States Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
5.3 Canada Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
5.4 Mexico Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
6 Europe Artificial Pancreas Device System by Countries
6.1 Europe Artificial Pancreas Device System Sales, Revenue and Market Share by Countries
6.1.1 Europe Artificial Pancreas Device System Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Artificial Pancreas Device System Revenue and Market Share by Countries (2013-2018)
6.2 Germany Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
6.3 UK Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
6.4 France Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
6.5 Russia Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
6.6 Italy Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
7 Asia-Pacific Artificial Pancreas Device System by Countries
7.1 Asia-Pacific Artificial Pancreas Device System Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Artificial Pancreas Device System Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Artificial Pancreas Device System Revenue and Market Share by Countries (2013-2018)
7.2 China Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
7.3 Japan Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
7.4 Korea Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
7.5 India Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
8 South America Artificial Pancreas Device System by Countries
8.1 South America Artificial Pancreas Device System Sales, Revenue and Market Share by Countries
8.1.1 South America Artificial Pancreas Device System Sales and Market Share by Countries (2013-2018)
8.1.2 South America Artificial Pancreas Device System Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
8.3 Argentina Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
8.4 Colombia Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
9 Middle East and Africa Artificial Pancreas Device System by Countries
9.1 Middle East and Africa Artificial Pancreas Device System Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Artificial Pancreas Device System Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Artificial Pancreas Device System Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
9.3 UAE Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
9.4 Egypt Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
9.5 Nigeria Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
9.6 South Africa Artificial Pancreas Device System Sales and Growth Rate (2013-2018)
10 Global Artificial Pancreas Device System Market Segment by Type
10.1 Global Artificial Pancreas Device System Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Artificial Pancreas Device System Sales and Market Share by Type (2013-2018)
10.1.2 Global Artificial Pancreas Device System Revenue and Market Share by Type (2013-2018)
10.2 Control-to-Range (CTR) System Sales Growth and Price
10.2.1 Global Control-to-Range (CTR) System Sales Growth (2013-2018)
10.2.2 Global Control-to-Range (CTR) System Price (2013-2018)
10.3 Threshold Suspended Device System Sales Growth and Price
10.3.1 Global Threshold Suspended Device System Sales Growth (2013-2018)
10.3.2 Global Threshold Suspended Device System Price (2013-2018)
10.4 Control - to - Target (CTT) System Sales Growth and Price
10.4.1 Global Control - to - Target (CTT) System Sales Growth (2013-2018)
10.4.2 Global Control - to - Target (CTT) System Price (2013-2018)
11 Global Artificial Pancreas Device System Market Segment by Application
11.1 Global Artificial Pancreas Device System Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Artificial Pancreas Device System Market Forecast (2018-2023)
12.1 Global Artificial Pancreas Device System Sales, Revenue and Growth Rate (2018-2023)
12.2 Artificial Pancreas Device System Market Forecast by Regions (2018-2023)
12.2.1 North America Artificial Pancreas Device System Market Forecast (2018-2023)
12.2.2 Europe Artificial Pancreas Device System Market Forecast (2018-2023)
12.2.3 Asia-Pacific Artificial Pancreas Device System Market Forecast (2018-2023)
12.2.4 South America Artificial Pancreas Device System Market Forecast (2018-2023)
12.2.5 Middle East and Africa Artificial Pancreas Device System Market Forecast (2018-2023)
12.3 Artificial Pancreas Device System Market Forecast by Type (2018-2023)
12.3.1 Global Artificial Pancreas Device System Sales Forecast by Type (2018-2023)
12.3.2 Global Artificial Pancreas Device System Market Share Forecast by Type (2018-2023)
12.4 Artificial Pancreas Device System Market Forecast by Application (2018-2023)
12.4.1 Global Artificial Pancreas Device System Sales Forecast by Application (2018-2023)
12.4.2 Global Artificial Pancreas Device System Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Artificial Pancreas Device System Picture
Table Product Specifications of Artificial Pancreas Device System
Figure Global Sales Market Share of Artificial Pancreas D